Kartik Bhamidipati, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.580 |
Why?
|
| Autoantibodies | 1 | 2021 | 2113 | 0.390 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4778 | 0.350 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 2159 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3733 | 0.260 |
Why?
|
| Nanoparticles | 3 | 2024 | 1964 | 0.230 |
Why?
|
| Drug Carriers | 2 | 2018 | 700 | 0.210 |
Why?
|
| Chemokine CXCL13 | 1 | 2021 | 62 | 0.180 |
Why?
|
| Receptors, CXCR5 | 1 | 2021 | 88 | 0.180 |
Why?
|
| Type C Phospholipases | 1 | 2021 | 285 | 0.170 |
Why?
|
| Lung | 4 | 2024 | 10033 | 0.170 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 433 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2207 | 0.170 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 2226 | 0.150 |
Why?
|
| Synovial Membrane | 1 | 2022 | 513 | 0.150 |
Why?
|
| Neutrophils | 2 | 2024 | 3776 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 1528 | 0.130 |
Why?
|
| Acute Lung Injury | 1 | 2016 | 377 | 0.100 |
Why?
|
| Epithelium | 1 | 2016 | 1599 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1811 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1587 | 0.090 |
Why?
|
| Epitopes | 1 | 2017 | 2523 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2535 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 4528 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2018 | 2395 | 0.080 |
Why?
|
| Regeneration | 1 | 2016 | 1517 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2023 | 1132 | 0.070 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2024 | 55 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11888 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15880 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2022 | 114 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 767 | 0.050 |
Why?
|
| Nanomedicine | 1 | 2024 | 286 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 22332 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 23601 | 0.040 |
Why?
|
| Liposomes | 1 | 2023 | 788 | 0.040 |
Why?
|
| Antibodies | 2 | 2017 | 2417 | 0.040 |
Why?
|
| Adsorption | 1 | 2018 | 200 | 0.040 |
Why?
|
| Inflammation | 1 | 2017 | 10850 | 0.030 |
Why?
|
| Acids | 1 | 2016 | 125 | 0.030 |
Why?
|
| Leukocytes | 1 | 2023 | 2027 | 0.030 |
Why?
|
| Mice | 4 | 2024 | 81819 | 0.030 |
Why?
|
| Animals | 6 | 2024 | 168764 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2016 | 755 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2017 | 594 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 633 | 0.030 |
Why?
|
| Humans | 6 | 2024 | 765968 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4642 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5988 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2018 | 1940 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 4137 | 0.020 |
Why?
|
| Wound Healing | 1 | 2016 | 2792 | 0.020 |
Why?
|
| Proteomics | 1 | 2016 | 3910 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 23707 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10429 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18293 | 0.010 |
Why?
|
| Brain | 1 | 2023 | 27171 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59889 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 88835 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 223009 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 223044 | 0.000 |
Why?
|
| Female | 1 | 2019 | 396112 | 0.000 |
Why?
|